Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 4/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP3 | P08254 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | MMP14 | P50281 | 1/20 | 0.31 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3478364 | 1.00 | CA2 (0.37) | CA2MAPK1CA1ALDH1A1CTSK | |
| SCHEMBL4634760 | 0.95 | CA2 (0.36) | CA2MAPK1CA1CTSKHCAR2 | |
| SCHEMBL15914715 | 0.94 | PLA2G2C (0.35) | CA2MAPK1CA1HCAR2 | |
| SCHEMBL1581727 | 0.89 | CA2 (0.35) | CA2MAPK1CA1ALDH1A1CTSK | |
| SCHEMBL4634756 | 0.84 | PLA2G2C (0.37) | CA2MAPK1CA1CTSKATM | |
| SCHEMBL15914714 | 0.83 | PLA2G2C (0.39) | CA2MAPK1CA1TSHR | |
| SCHEMBL18241671 | 0.81 | CTSK (0.33) | CA2MAPK1CA1CTSK | |
| SCHEMBL165679 | 0.80 | CA2 (0.40) | CA2MAPK1CA1CTSKATM | |
| SCHEMBL15661587 | 0.79 | CA2 (0.35) | CA2MAPK1CA1CTSK | |
| SCHEMBL114019 | 0.78 | CA2 (0.38) | CA2MAPK1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260109105-A1 | METHOD FOR PRODUCING STRETCHED FILM | KANEKA CORPORATION (JP) | 2026-04-23 | — | — | US | disclosed |
| US-20250304785-A1 | RESIN COMPOSITION FOR STRETCHED FILM MOLDING | KANEKA CORPORATION (JP) | 2025-10-02 | — | — | US | disclosed |
| WO-2024043327-A1 | POLYMER, RESIN COMPOSITION, MOLDED BODY, AND POLYMER PRODUCTION METHOD | 住友化学株式会社 | 2024-02-29 | — | — | WO | disclosed |
| WO-2024043326-A1 | HYDROPHILIC OIL REPELLENT POLYMER | 住友化学株式会社 | 2024-02-29 | — | — | WO | disclosed |
| CN-114316711-A | Hydrophilic water-slipping agent, laminate, and method for forming film of hydrophilic water-slipping agent | 荒川化学工业株式会社 | 2022-04-12 | — | — | CN | disclosed |
| CN-103725211-B | EVA film encapsulated in solar battery and preparation method of EVA film | SUZHOU TECH SOLAR FILM MAT CO | 2015-05-06 | — | — | CN | disclosed |
| CN-103725211-A | EVA film encapsulated in solar battery and preparation method of EVA film | SUZHOU TECH SOLAR FILM MAT CO | 2014-04-16 | — | — | CN | disclosed |
| EP-1806614-B1 | HIGHLY OXYGEN-PERMEABLE HYDRATED OCULAR LENS | SEED CO LTD (JP) | 2011-04-20 | — | — | EP | disclosed |
| US-7781536-B2 | Highly oxygen-permeable hydrated ocular lens | SEED CO., LTD. (JP) | 2010-08-24 | — | — | US | disclosed |
| US-20080094570-A1 | Highly Oxygen-Permeable Hydrated Ocular Lens | SEED CO., LTD. (JP) | 2008-04-24 | — | — | US | disclosed |
| EP-1806614-A1 | HIGHLY OXYGEN-PERMEABLE HYDRATED OCULAR LENS | Seed Co., Ltd. (JP) | 2007-07-11 | — | — | EP | disclosed |
| US-7193226-B2 | Scratch resistant moisture-protecting parylene layers | AGFA-GEVAERT (BE) | 2007-03-20 | — | — | US | disclosed |
| EP-1541333-A1 | Scratch resistant moisture-protecting parylene layers | Agfa-Gevaert (BE) | 2005-06-15 | — | — | EP | disclosed |
| US-20050067584-A1 | Scratch resistant moisture-protecting parylene layers | AGFA NV (BE) | 2005-03-31 | — | — | US | disclosed |
| WO-1999054391-A1 | PROCESS FOR THE PREPARATION OF EXPANDABLE POLYMER PARTICLES | NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) | 1999-10-28 | — | — | WO | disclosed |
| WO-1994010221-A1 | ACRYLIC BASED POWDER PAINT | DSM N.V. (NL) | 1994-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260109105-A1 | METHOD FOR PRODUCING STRETCHED FILM | TPM3, TPM4, HACD3 | CA2 901/4885MAPK1 4454/4885CA1 2148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.